Total Penectomy — Cost, Top Hospitals & Success Rates | MyMedicPlus

Total penectomy is the complete surgical removal of the penis, performed primarily as a curative surgical treatment for penile cancer when the disease is too extensive for organ-sparing approaches. It is one of the most radical procedures in urologic oncology and represents the most extensive option on the surgical spectrum for penile malignancy, reserved for cases where partial penectomy, glansectomy, or other organ-preserving techniques cannot achieve clear oncological margins.

Penile cancer is a rare malignancy, accounting for fewer than 1% of all male cancers in Western countries but carrying a higher incidence in sub-Saharan Africa, South America, and parts of Asia — regions where human papillomavirus (HPV) infection, lack of circumcision, and limited access to early diagnosis contribute to a greater burden of locally advanced disease at presentation. In these settings, total penectomy is more frequently required as the presenting disease stage is often higher.

The procedure involves surgical excision of the entire penile shaft, together with the corpora cavernosa and corpus spongiosum, to the level of the pubic rami. Because the urethra is removed along with the penis, urinary diversion via a permanent perineal urethrostomy — an opening created in the perineum (the area between the scrotum and anus) through which the patient urinates in a downward-sitting position — is a necessary component of the procedure.

Total penectomy is undertaken with curative intent for localized or locally advanced penile cancer without distant metastasis, or with palliative intent in patients with uncontrolled local disease causing bleeding, pain, or infection that significantly impairs quality of life. It is almost always considered only after a multidisciplinary oncology team review, which should include urologic oncology, medical oncology, radiation oncology, reconstructive surgery, and psycho-oncology.

The physical and psychological impact of total penectomy is profound, and comprehensive peri-operative and post-operative support — including psychological counseling, sexual rehabilitation, and peer support — is an integral part of modern penile cancer care.

Total penectomy is reserved for specific clinical situations where the extent of disease or anatomical involvement precludes less radical options.

Primary Indication: Penile Squamous Cell Carcinoma (SCC)

Squamous cell carcinoma accounts for over 95% of all penile cancers. Total penectomy is indicated when:

• Tumors involve the proximal penile shaft: Disease at the base of the penis or involving the crura cannot be excised with adequate margins (typically 5 mm or more) by partial penectomy while preserving a functional penile stump.
• T2–T4 disease with proximal shaft invasion: Tumors invading the corpus cavernosum (T2), urethra (T3), or adjacent structures such as scrotum, prostate, or pubic bone (T4) often require total penectomy for oncological control.
• Recurrence after prior organ-sparing surgery: Patients who experience disease recurrence following partial penectomy, laser ablation, or radiation therapy may require total penectomy for salvage treatment.
• Inadequate residual functional stump after partial penectomy: If the disease requires removal of tissue that would leave a penile remnant too short for urination while standing (less than approximately 3 cm), total penectomy with perineal urethrostomy is functionally preferable.

Other Penile Malignancies

Rare penile tumors — including melanoma, sarcoma, Paget's disease, or verrucous carcinoma (Buschke-Lowenstein tumor) — may require total penectomy when they are locally advanced or when wide-margin excision necessitates complete organ removal.

Severe Non-Oncologic Conditions (Rare)

Exceptionally rarely, total penectomy may be performed for refractory priapism with irreversible penile necrosis, advanced Fournier's gangrene with complete penile devitalization, or severe traumatic injury with non-viable penile tissue — situations where tissue preservation is not possible.

Total penectomy is not performed without a thorough oncological, surgical, and psychological evaluation. The decision is made by a multidisciplinary tumor board and involves the patient in shared decision-making.

Oncological Assessment

• Histological confirmation: Biopsy-proven penile malignancy is required before any surgical planning. Partial biopsies may be followed by mapping biopsies in ambiguous cases.
• Clinical staging: MRI of the penis with artificial erection (dynamic MRI) is the gold standard for assessing depth of corpus cavernosum invasion. CT scan of the abdomen and pelvis and chest imaging assess regional lymph node involvement and distant metastasis. PET-CT may be used in high-risk or restaging cases.
• Lymph node assessment: Dynamic sentinel lymph node biopsy or modified inguinal lymph node dissection is performed alongside total penectomy or in a staged procedure, as inguinal lymph node involvement is the single most important prognostic factor in penile cancer.

Fitness for Surgery

• Ability to tolerate general or spinal anesthesia
• No evidence of distant metastatic disease in patients undergoing curative intent surgery
• Adequate renal function for post-operative urinary management
• Optimization of comorbidities (diabetes, cardiovascular disease, nutritional status) before major surgery

Psychosocial Readiness

• Pre-operative psychological assessment and counseling by a trained psycho-oncologist or psychiatrist
• Discussion of body image, sexual identity, relationship impact, and quality of life expectations
• Access to post-operative peer support networks (penile cancer patient groups) where available
• Partner counseling and involvement in the decision-making process where appropriate and desired

When Organ-Sparing Is No Longer Appropriate

The treating team confirms that organ-sparing options — including partial penectomy, glansectomy, wide local excision, radiation, or laser therapy — cannot achieve clear oncological margins or are inappropriate given the disease extent or prior treatment history.

Total penectomy is a major urologic surgery requiring specialized expertise. The approach is tailored to the extent of disease, lymph node status, and whether reconstructive procedures are planned.

Standard Total Penectomy with Perineal Urethrostomy

The definitive procedure involves en-bloc excision of the entire penis — including the glans, penile shaft, corpora cavernosa bilaterally, and corpus spongiosum — transected at the level of the pubic rami. The urethra is divided at an appropriate proximal level with clear margins and is brought out through a surgically created opening in the perineum (perineal urethrostomy), positioned anteriorly between the scrotum and anus. This creates a permanent, stable urinary outlet through which the patient urinates in a sitting or squatting position. Meticulous skin closure and stoma construction are important to prevent urethral stenosis and urinary complications.

Total Penectomy with Inguinal/Ilioinguinal Lymph Node Dissection

For patients with clinically palpable or biopsy-positive inguinal lymph nodes, bilateral or unilateral inguinal lymph node dissection (or ilioinguinal dissection) is performed at the same sitting or in a staged procedure. This is a key determinant of cure in node-positive penile cancer. Modified templates that spare the saphenous vein and reduce the extent of dissection are preferred when feasible to reduce lymphedema morbidity.

Neoadjuvant Chemotherapy Followed by Surgery

For patients with initially unresectable or borderline resectable locally advanced disease (bulky inguinal nodes or T4 disease), neoadjuvant combination chemotherapy (typically cisplatin-based regimens: TIP — paclitaxel, ifosfamide, cisplatin; or BMP — bleomycin, methotrexate, cisplatin) may downstage the disease to permit subsequent curative surgery. Response to chemotherapy is reassessed by imaging before proceeding to resection.

Palliative Total Penectomy

In patients with metastatic disease, total penectomy may be offered for local symptom control — addressing bleeding, infection, malodor, or severe pain that significantly impairs quality of life — with the explicit understanding that the procedure is not curative. Palliative intent and goals of care must be carefully discussed and documented.

Reconstructive Options

While penile reconstruction (phalloplasty using radial forearm free flap or other techniques) exists in principle, it is rarely pursued in the context of penile cancer surgery due to the oncological requirement for clear margins, the complexity of reconstruction, and the need for ongoing cancer surveillance. Reconstruction is more commonly performed in gender-affirming surgery. The oncological team must endorse the safety of any reconstructive procedure in the cancer context.

When performed for appropriate oncological indications, total penectomy provides significant clinical benefits in terms of cancer control and symptom relief.

Local Disease Control and Potential Cure

For localized penile cancer without nodal or distant metastasis, total penectomy with clear histological margins offers the highest probability of local disease control. Five-year disease-specific survival rates for node-negative penile cancer treated with total penectomy are reported at 70–90% in major series, reflecting the curative potential of radical surgery in appropriately selected patients.

Relief from Locally Advanced Symptoms

For patients with large, ulcerated, bleeding, infected, or odorous penile tumors, even in the setting of metastatic disease, total penectomy can dramatically improve quality of life by eliminating these distressing local symptoms. Tumor-related hemorrhage, recurrent infection, and severe local pain are effectively resolved by surgical excision.

Oncologically Superior Margins

When organ-sparing surgery risks positive or close margins, total penectomy reliably achieves complete excision of the primary tumor, eliminating the risk of local recurrence that could compromise subsequent management options.

Definitive Urinary Control

A well-constructed perineal urethrostomy provides a reliable, continent urinary outlet. Most patients adapt to perineal voiding without significant urinary symptoms, and urethral stenosis — the main late complication — is manageable with regular dilatation or revision in the minority of patients who develop it.

Psychological Relief from Disease Burden

For patients living with painful, disfiguring, or odorous penile tumors, surgical excision removes a significant and constant source of physical and psychological distress. Studies report that despite the psychological impact of penile loss, many patients experience an overall improvement in wellbeing and quality of life after surgery compared to the pre-operative burden of active advanced disease.

Total penectomy is associated with a range of surgical complications and profound psychosocial consequences that must be addressed with equal seriousness. Comprehensive peri-operative and long-term support is essential.

Immediate Surgical Complications

• Haemorrhage: Intraoperative or post-operative bleeding from the dorsal penile artery or cavernous arteries, managed with careful surgical haemostasis.
• Wound dehiscence: Poor wound healing, particularly in patients with diabetes, malnutrition, or prior radiation, can result in wound breakdown. Careful nutritional optimization pre-operatively reduces this risk.
• Infection: Wound and urinary tract infection are the most common post-operative complications; managed with antibiotics and appropriate wound care.
• Perineal haematoma: Blood collection in the perineal wound space may require drainage.

Urological Complications

• Urethral/perineal urethrostomy stenosis: Narrowing of the urinary opening occurs in 10–20% of patients over time, causing difficulty urinating or urinary retention. Managed with regular urethral dilatation or surgical revision (meatoplasty).
• Urinary stream splaying or difficulty directing urine: Adapting to perineal urination requires a period of adjustment; most patients become comfortable with voiding in a seated position.
• Urinary tract infections: Increased risk with perineal urethrostomy; managed with appropriate antibiotic courses and good perineal hygiene.

Oncological Risks

• Positive surgical margins: Despite radical surgery, microscopic tumor at the margin may require adjuvant radiation therapy or re-excision.
• Inguinal lymph node recurrence: Regional nodal recurrence is possible even after lymph node dissection; ongoing surveillance imaging is essential.

Lymphedema

When bilateral inguinal lymph node dissection is performed, lymphedema of the lower limbs and genitalia occurs in 20–50% of patients. Compression garments, lymphatic massage (manual lymphatic drainage), physiotherapy, and in some cases surgical lymphatic procedures are used in management.

Psychosocial and Sexual Impact

Total penectomy has profound effects on body image, gender identity, sexual function, and intimate relationships. Loss of the penis eliminates penetrative sexual intercourse and penile orgasm, though many patients retain erotic sensation, libido, and the capacity for non-penetrative sexual activity. Depression, anxiety, post-traumatic stress, relationship difficulties, and sexual dysfunction are well-documented sequelae and require proactive psychological support. Access to psycho-oncology, sex therapy, and peer support networks is an integral component of holistic penile cancer care.

Recovery from total penectomy is a multi-phase process involving physical healing, functional adaptation, and ongoing oncological surveillance. Long-term follow-up by a specialist team is essential for early detection of disease recurrence and management of late complications.

Hospital Recovery (3–7 Days)

Patients typically remain in hospital for 3–7 days post-operatively. A urethral catheter is placed through the perineal urethrostomy intraoperatively and removed once the stoma is adequately healed, usually at 5–10 days. Pain is managed with a multimodal regimen including analgesics, anti-inflammatories, and regional anesthesia where available. Wound care is initiated by nursing staff and taught to the patient before discharge. Mobilization is encouraged early to prevent thromboembolism.

Urethrostomy Care and Adaptation

The perineal urethrostomy requires regular cleaning to maintain hygiene and prevent encrustation. Patients are instructed to void in a seated position. The urinary stream should be observed regularly for any reduction in flow rate, which may indicate developing stenosis. Urethral dilatation may be required at clinic visits if stenosis develops. Most patients adapt well to perineal voiding within a few weeks.

Wound Healing

The perineal and pubic wounds typically heal within 3–6 weeks. Patients receiving adjuvant radiation therapy may experience delayed healing. Activity restrictions (no strenuous exercise, heavy lifting, or prolonged sitting on firm surfaces) apply for the initial 4–6 weeks.

Oncological Surveillance

Surveillance intensity depends on disease stage and pathological findings. A standard post-operative follow-up schedule typically includes:

• Clinical examination of the wound, perineal urethrostomy, and inguinal regions every 3 months for the first 2 years
• CT scan of abdomen, pelvis, and chest every 6 months for 2 years, then annually for a total of 5 years
• PET-CT for equivocal findings on CT

Psychological and Rehabilitation Support

Psycho-oncology input should be offered before and after surgery and maintained as a long-term resource. Support may include individual psychotherapy, couple or relationship counseling, sex therapy (adapted to the patient's post-operative anatomy and sexual goals), peer support groups (in-person or online), and — in specialist centres — penile cancer patient advocacy organizations. Psychological follow-up is as essential as physical surveillance.

Total penectomy is a major oncological surgery, and costs encompass the full spectrum of cancer care from diagnosis through long-term surveillance. In countries with universal healthcare or comprehensive cancer coverage, most costs are subsidized; in private-pay systems, expenses can be substantial.

Primary Cost Components

• Pre-operative staging: MRI penis, CT/PET-CT imaging, biopsy, histopathology, lymph node assessment, anesthesia review, and multidisciplinary tumor board fees
• Surgical fees: Urologic oncologist and any assisting surgeons; lymph node dissection adds to operative complexity and time
• Anesthesia: General or spinal anesthesia with monitoring for a major abdominal/perineal procedure
• Hospital fees: Inpatient stay of 3–7 days, operating theatre, recovery room, nursing care
• Pathological analysis: Detailed histopathological examination of the surgical specimen and lymph nodes (margin assessment, nodal staging)
• Adjuvant treatment: Post-operative chemotherapy or radiation therapy if indicated adds substantial cost
• Post-operative care: Wound care, catheter supplies, lymphedema management (compression garments, manual lymphatic drainage sessions), and urological follow-up
• Oncological surveillance: 5-year surveillance imaging and clinic visits
• Psychological support: Psycho-oncology, psychiatry, couple counseling, sex therapy sessions

Regional Cost Estimates (Approximate)

• United States: USD 20,000–60,000+ for surgery and hospital stay; significantly higher with lymph node dissection, adjuvant treatment, and surveillance
• United Kingdom (NHS): Fully covered for eligible patients via NHS specialist urological oncology centres
• India: USD 3,000–8,000 at leading cancer hospitals including surgical, anesthesia, and hospital stay costs
• Thailand: USD 5,000–12,000 at accredited cancer centres

Patients seeking care outside their home country for cost reasons should confirm that the chosen centre has specialist urologic oncology expertise, appropriate pathological reporting standards, and the capability to manage complications. Cancer surgery requires post-operative surveillance that may be logistically complex across international borders.

Organ-sparing approaches are strongly preferred whenever oncologically safe. The treating urologic oncologist must balance oncological cure with preservation of quality of life, and shared decision-making between patient and clinical team is fundamental to the treatment planning process.

Partial Penectomy

Removal of the distal penis while preserving a proximal penile stump sufficient for voiding in a standing position. Appropriate for tumors of the glans or distal shaft (T1–T2) that can be excised with adequate margins (5 mm or more) while leaving a functional stump of at least 3 cm. Partial penectomy is oncologically equivalent to total penectomy for appropriately staged disease and is strongly preferred when feasible. Local recurrence rates are approximately 5–10%.

Glansectomy

Removal of the glans (head of the penis) only, preserving the penile shaft. Suitable for well-defined, superficial tumors confined to the glans (Tis, T1, selected T2 without corpus involvement). Reconstruction of the glans surface using split-thickness skin graft or other tissue creates acceptable cosmetic and functional results. Glansectomy has excellent oncological outcomes for suitable cases and is increasingly performed at specialist centres.

Wide Local Excision

Surgical excision with clear margins for very superficial (Tis, T1a) penile tumors, particularly on the foreskin or prepuce. Circumcision alone may be adequate for disease confined to the foreskin.

Laser Ablation (CO2 or Nd:YAG Laser)

For superficial (Tis, Ta, T1a) penile squamous cell carcinoma or carcinoma in situ (erythroplasia of Queyrat, Bowen's disease), laser ablation can effectively treat disease while preserving penile appearance and function. Requires careful patient selection, meticulous mapping biopsies to confirm depth, and close endoscopic surveillance for recurrence.

Radiation Therapy (External Beam or Brachytherapy)

Primary radiation therapy — either external beam radiation or brachytherapy (interstitial or mold technique) — can achieve organ preservation for selected T1–T2 penile tumors with acceptable local control rates (60–80% at 5 years). Advantages: avoids penile loss; long-term complications include urethral stricture, penile fibrosis, and necrosis in a minority of patients. Salvage penectomy is required for radiation failures. Brachytherapy is available at specialist radiation oncology centres.

Systemic Chemotherapy

Used in the neoadjuvant setting to downstage locally advanced or borderline resectable disease before surgery, or as primary treatment for metastatic disease. Cisplatin-based regimens (TIP, BMP) are most commonly used. Systemic chemotherapy alone is not curative for localized penile cancer and is not a substitute for surgical resection of the primary tumor in operable patients.